Vistin Pharma ASA will release its fourth quarter and preliminary 2024 results on Thursday 13th of February 2025. Vistin Pharma will host a conference call for all shareholders and interested parties ...
The Healthy on MSN17h
Nearly 7,000 Bottles of a Heart and Diabetes Medication Recalled in At Least One StateHowever, a recent recall affecting 6,804 bottles of metformin means some of the 20 million Americans on metformin will want ...
Hyderabad: Granules India, a vertically integrated Indian pharmaceutical company, has announced the resignation of Riaz Ahmed ...
AM(IST)on Friday in an upbeat market. Biocon Ltd.(up 1.88 per cent), Zydus Lifesciences Ltd.(up 1.29 per cent), Dr. Reddy's ...
Granules India's subsidiary, GPI, receives USFDA approval for Lisdexamfetamine Dimesylate Capsules, expanding ADHD treatment ...
Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.
Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and ...
The Nifty Pharma index closed on a positive note on Thursday. Shares of Laurus Labs Ltd.(up 8.22 per cent), Granules India ...
Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules: Our Bureau, Bengaluru Thursday, January 30, 2025, 16:15 Hrs [IST] Granules India ...
Granules India receives USFDA approval for its generic Lisdexamfetamine Dimesylate capsules, indicated for the treatment of ...
Hyderabad: Granules India Limited, a vertically integrated Indian pharmaceutical company, has announced that its wholly-owned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback